1,1-二甲基-1-十六烷胺 | 35177-30-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1,1-二甲基-1-十六烷胺
• 英文名称: 1,1-dimethyl-1-hexadecanamine
• 英文别名: Dimethylhexadecan-1-amine；2-methylheptadecan-2-amine
• CAS: 35177-30-1
• 化学式: C₁₈H₃₉N
• 分子量: 269.514
• InChiKey: OESQOSXKPZAPLP-UHFFFAOYSA-N

物化性质

• 沸点：
  339.2±10.0 °C(Predicted)
• 密度：
  0.818±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7.7
• 重原子数：
  19
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  正丁基锂 、 1,1-二甲基-1-十六烷胺 以39%的产率得到
  参考文献：
  名称：

  RICHEY, H. G. ,, JR;CABRE, S., J. ORG. CHEM., 1983, 48, N 21, 3822-3825

  摘要：

  DOI：

文献信息

• [EN] SOLVENTS<br/>[FR] SOLVANTS
  申请人：BIONIQS LTD

  公开号：WO2009034329A1

  公开（公告）日：2009-03-19

  There is described the use of a protic ionic liquid comprising a trialkylammonium salt as a solvent.

  这里描述了一种包含三烷基铵盐的质子离子液体作为溶剂的使用。
• Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
  申请人：Rogers D. Robin

  公开号：US20070093462A1

  公开（公告）日：2007-04-26

  Disclosed are ionic liquids and methods of preparing ionic liquid compositions of active pharmaceutical, biological, nutritional, and energetic ingredients. Also disclosed are methods of using the compositions described herein to overcome polymorphism, overcome solubility and delivery problems, to control release rates, add functionality, enhance efficacy (synergy), and improve ease of use and manufacture.

  揭示了离子液体及制备活性药物、生物、营养和能量成分的离子液体组合物的方法。还揭示了利用本文描述的组合物的方法，以克服多型性、克服溶解度和输送问题、控制释放速率、增加功能性、增强功效（协同作用）以及改善易用性和制造工艺。
• NANOPARTICLES COMPRISED OF SHELLS ASSOCIATED WITH CHARGED ENTITIES AND FORMED FROM MONOMERS AND METHODS OF MAKING AND USING NANOPARTICLES
  申请人：WALTERS Marc

  公开号：US20160367705A1

  公开（公告）日：2016-12-22

  The present invention relates to relates to a nanoparticle that includes a shell formed from a first monomer having a first charge and a second monomer different than the first monomer. The first and second monomers are copolymerized, and the shell encapsulates a core region and is associated with a charged entity having a second charge of opposite sign to the first charge. The present invention further relates to a nanoparticle having a neutral charge. The present invention further relates to nanoparticle dispersions, methods of making the nanoparticle, methods of method of imaging, methods of delivering drugs, and methods of delivering a high concentration of contrast enhancing and/or imaging agents.

  本发明涉及一种纳米颗粒，其包括由具有第一电荷的第一单体和与第一单体不同的第二单体形成的壳。第一和第二单体共聚合，壳包裹着一个核心区域，并与具有与第一电荷相反的第二电荷的带电实体相关联。本发明还涉及一种带有中性电荷的纳米颗粒。本发明还涉及纳米颗粒分散体、制备纳米颗粒的方法、成像方法、药物传递方法以及传递高浓度对比增强和/或成像剂的方法。
• [EN] DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF<br/>[FR] LIQUIDES IONIQUES À DOUBLE FONCTION ET SELS DE CEUX-CI
  申请人：UNIV ALABAMA

  公开号：WO2010078300A1

  公开（公告）日：2010-07-08

  Disclosed herein are ionic liquid compositions comprising active pharmaceutical, biological, and nutritional compounds, and methods of use. Further disclosed are compositions of matter including liquid ion pairs alone or in solution and their use; compositions of ionic liquids that are 'solvated,' for example, 'hydrated' and their uses.

  本文揭示了包括活性药物、生物学和营养化合物的离子液体组合物，以及其使用方法。进一步揭示了包括液态离子对的物质组合物，单独或溶解后使用；以及离子液体的“溶剂化”组合物，例如“水合”的组合物及其用途。
• Phosphate esters dispersants
  申请人：Thetford Dean

  公开号：US20050256226A1

  公开（公告）日：2005-11-17

  A dispersant which comprises the reaction product of a phosphating agent such as polyphosphoric acid and a compound of formula R—OH wherein R is a residue of a polyester and/or polyether having a polymerisation terminating group and where the ratio of each phosphorus atom of the phosphating agent to RO—H is from 1.3:1 to 3:1. The dispersants are thought to be pyrophosphates.

  这种分散剂包括磷酸化剂（如聚磷酸）和化合物R—OH（其中R是聚酯和/或聚醚的残基，具有聚合终止基团）的反应产物，其中磷酸化剂中每个磷原子与RO—H的比例为1.3:1到3:1。这些分散剂被认为是焦磷酸盐。